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Abstract: The drivers and patterns of zoonotic virus emergence in the human population are 
poorly understood. The mosquito Aedes aegypti is a major arbovirus vector native to Africa that 
invaded most of the world’s tropical belt over the past four centuries, following the evolution of 
a ‘domestic’ form that specialized in biting humans and breeding in human water-storage 5 
containers. Here, we show that human specialization and subsequent spread of Ae. aegypti out of 
Africa were accompanied by an increase in its intrinsic ability to acquire and transmit the 
emerging human pathogen, Zika virus. Therefore, the recent evolution and global expansion of 
Ae. aegypti promoted arbovirus emergence not solely through increased vector-host contact, but 
also as a result of enhanced vector susceptibility. 10 
 
One Sentence Summary: Increased susceptibility of globally invasive Ae. aegypti populations 
facilitated Zika virus emergence outside Africa. 
  
Submitted Manuscript: Confidential 
 
 
5 
 
 
Main Text: 
 
The mosquito Aedes aegypti is found throughout the tropics and sub-tropics and its range is 
predicted to further expand with climate change (1). It consists of two subspecies originally 5 
described based on morphological and ecological differences (2) and subsequently supported by 
modern population genetics (3). The globally invasive subspecies Ae. aegypti aegypti (Aaa) 
thrives in urban environments of Asia and the Americas where it oviposits in artificial containers 
and preferentially bites humans. The African subspecies Ae. aegypti formosus (Aaf) inhabits both 
urban and forest habitats of sub-Saharan Africa and bites a variety of vertebrate animals (4, 5). 10 
Coexistence of the two subspecies as genetically distinct entities has only been documented 
along the coast of Kenya, whereas in some locations of Senegal and Angola Ae. aegypti 
populations consist of a genetic blend of Aaa and Aaf (3, 6, 7). 
 
The human specialist Aaa is thought to have evolved from generalist ancestors in Western Africa 15 
about 5,000-10,000 years ago (6, 8). ‘Domestication’ allowed the global expansion of Aaa 
during the slave-trading period (17th-19th centuries), which in turn fueled the first global 
pandemics of yellow fever and dengue (9). Today, Ae. aegypti is the most important global 
vector of arboviruses, including not only dengue virus (DENV) and yellow fever virus (YFV) 
but also newly emerging arboviruses such as Zika virus (ZIKV) and chikungunya virus (10). The 20 
high efficiency of Aaa as an arbovirus vector is generally attributed to its strong preference for 
humans and proclivity to lay eggs in man-made containers (9). 
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Despite ample evidence for variation in flavivirus susceptibility within and between Ae. aegypti 
populations (11), surprisingly little attention has been paid to the consequences of Ae. aegypti’s 
‘domestication’ and global expansion out of Africa for its innate ability to acquire arbovirus 
infections and subsequently become infectious. A few studies in the 1970s and 1980s, motivated 
by the historical absence of yellow fever in Asia, ruled out the hypothesis that Asian populations 5 
of Ae. aegypti were inefficiently infected by YFV, however they noticed that Aaf populations 
were generally less susceptible to YFV than their Aaa counterparts (12, 13). A similar conclusion 
was made for DENV susceptibility (14), but experimental variation in virus titers of the artificial 
blood meals in these early studies did not allow a formal worldwide comparison. 
 10 
Here, we investigated the worldwide variation of Ae. aegypti susceptibility to ZIKV infection 
using a panel of 14 laboratory colonies recently established (2-16 laboratory generations) from 
field-collected specimens (Table S1). ZIKV is a flavivirus (family: Flaviviridae) first isolated 
from a sentinel monkey in Uganda in 1947 (15) and mainly transmitted among humans by Ae. 
aegypti. The first reported human epidemic of ZIKV occurred in 2007 on the Pacific island of 15 
Yap, Micronesia (16). Subsequently, larger ZIKV outbreaks were recorded in French Polynesia 
and other Pacific islands during 2013-2014 (17). In 2015, ZIKV was detected in Brazil from 
where it rapidly spread across the Americas and the Caribbean, causing hundreds of thousands of 
human cases (18). The factors underlying the explosiveness and magnitude of ZIKV emergence 
in the Pacific and the Americas are still poorly understood. Reciprocally, the lack of major 20 
human epidemics of ZIKV in regions with seemingly favorable conditions, such as Africa or 
continental Asia, remains largely unexplained to date (18). 
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To compare ZIKV susceptibility between our Ae. aegypti colonies, we generated empirical dose-
response curves based on a standardized membrane-feeding assay (Fig. S1A). Dose-response 
curves account for the strong dose-dependency of infection success (19, 20) and provide an 
absolute measure of susceptibility, which can be summarized by the virus dose infecting 50% of 
blood-fed mosquitoes (50% oral infectious dose; OID50). Multiple blood meals are known to 5 
enhance systemic virus dissemination in ZIKV-infected Ae. aegypti but they do not affect initial 
infection prevalence (21), therefore a single infectious blood meal is adequate to obtain relevant 
OID50 estimates. Because ZIKV susceptibility is also influenced by the virus strain (20, 22), we 
used a panel of seven wild-type ZIKV strains encompassing the current viral genetic diversity 
(Table S2). 10 
 
We first measured ZIKV susceptibility in a worldwide panel of eight Ae. aegypti colonies (Table 
S1) originating from Africa (Cameroon, Uganda, Gabon), the Americas (Colombia, Guadeloupe, 
French Guiana) and Asia (Thailand, Cambodia). We individually scored the infection status of 
3,113 female Ae. aegypti following oral exposure to three different infectious doses of six ZIKV 15 
strains. The infection status depended on a three-way interaction between infectious dose, ZIKV 
strain and mosquito population (multivariate logistic regression: p=0.0238), indicating that the 
dose-response curves differed significantly among virus-population pairs (Fig. 1A). When 
mosquito populations were nested within their continent of origin (Asia, Africa, Americas) in the 
statistical model, there was a strong effect of the continent (p<0.0001), which was mainly driven 20 
by the significantly lower ZIKV susceptibility of the three African mosquito populations. Across 
the ZIKV strains, the OID50 estimates (Table S3) ranged from 6.3 to 8.1 log10 FFU/ml for the 
three African populations and from 4.7 to 6.8 log10 FFU/ml for the five non-African populations 
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(Fig. 1B). We confirmed that variation in ZIKV susceptibility did not simply reflect differences 
in colonization history between the mosquito populations. We analyzed the OID50 estimates as a 
function of the average number of generations spent in the laboratory and found no statistical 
support for an effect of the generation (analysis of variance [ANOVA]: p=0.8236), or an 
interaction effect between the ZIKV strain and the generation (ANOVA: p=0.8618). 5 
 
The three African colonies of our worldwide panel were significantly less susceptible to ZIKV 
infection than their non-African counterparts, however they did not represent the full extent of 
Ae. aegypti genetic diversity in the ancestral range of the species (6). These three colonies came 
from places expected to harbor relatively pure Aaf populations, whereas other African 10 
populations from the Sahelian region show signatures of mixed ancestry with globally invasive 
Aaa (7, 8). To expand our assessment of African Ae. aegypti populations, we examined a panel 
of six additional mosquito colonies (Table S1) originating from Senegal (NGO, KED), Ghana 
(KUM), Uganda (ENT) and Kenya (KAK, RAB) (7). We measured their ZIKV susceptibility 
with our standardized membrane-feeding assay and the colonies from Gabon and Guadeloupe of 15 
our worldwide panel were included as references (Fig. 2A). The six African colonies differed 
significantly in their dose response to the ZIKV_Cambodia_2010 strain (multivariate logistic 
regression excluding reference colonies: p<0.0001; n=271), but not to the ZIKV_Senegal_2011 
strain (p=0.0587; n=363). The OID50 estimates (Table S3) ranged from 6.3 (NGO) to 7.9 (KED) 
log10 FFU/ml for the ZIKV_Cambodia_2010 strain and from 4.9 (NGO) to 6.2 (KED) log10 20 
FFU/ml for the ZIKV_Senegal_2011 strain (Fig. 2B). There was no evidence for an effect of the 
laboratory generation (ANOVA: p=0.7399) or an interaction effect between the ZIKV strain and 
the laboratory generation (ANOVA: p=0.9236) on the OID50 estimates. Although the 
Submitted Manuscript: Confidential 
 
 
9 
 
ZIKV_Senegal_2011 strain was more infectious overall, we noticed that for both virus strains the 
most and least susceptible African colonies were the same (NGO and KED, respectively). These 
two colonies are expected to differ genetically according to a recent study that analyzed the 
whole-genome sequences of their wild progenitors (7). In that study, ADMIXTURE analysis 
identified three genomic clusters (East Africa, Central/West Africa, and globally invasive 5 
‘domestic’ ancestry components) and detected a variable level of ‘domestic’ ancestry in several 
African Ae. aegypti populations. For instance, the average proportion of ‘domestic’ ancestry in 
the wild progenitors was 37.4% for NGO and 0.86% for KED (7). We thus analyzed ZIKV 
susceptibility as a function of the level of ‘domestic’ ancestry and found that they were 
positively associated (Fig. 2C), both for the ZIKV_Cambodia_2010 strain (square root 10 
regression: p=0.0047; R2=0.761) and for the ZIKV_Senegal_2011 strain (square root regression: 
p=0.0437; R2=0.519). When omitting the pure Aaa reference population from Guadeloupe, the 
relationship was still significant for the ZIKV_Cambodia_2010 strain (linear regression: 
p=0.0047; R2=0.824) but no longer for the ZIKV_Senegal_2011 strain (linear regression: 
p=0.1189; R2=0.414). These results provide further evidence for the higher ZIKV susceptibility 15 
of the ‘domestic’ subspecies Aaa relative to the African subspecies Aaf. 
 
To investigate the genetic basis of Ae. aegypti worldwide variation in ZIKV susceptibility, we 
intercrossed the colony from Guadeloupe (susceptible parent; 100% Aaa) with the colony from 
Gabon (resistant parent; 7.3% Aaa) to perform quantitative trait locus (QTL) mapping by bulk 20 
segregant analysis (Fig. S2). In two reciprocal intercrosses, F1 hybrids displayed a level of 
susceptibility to the ZIKV_Cambodia_2010 strain that was intermediate but closer to the 
resistant parent (Fig. 3A), suggesting that resistant alleles were partially dominant. The level of 
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ZIKV susceptibility remained intermediate during the following five generations of both 
intercrosses (Fig. 3A). After three generations of recombination, we genotyped phenotypic pools 
of the F4 progeny based on their ZIKV-resistant (uninfected) or ZIKV-susceptible (infected) 
phenotype (2 replicate pools of 48 individuals per phenotype). We used a total of ∼230,000 
single-nucleotide polymorphisms identified on a genome-wide scale by restriction site-associated 5 
DNA sequencing to detect deviations in allele frequencies between ZIKV-resistant and ZIKV-
susceptible pools. In the first intercross (Guadeloupe males × Gabon females), we detected a 
cluster of five highly significant QTL associated with infection status (false discovery rate 
[FDR]<0.001) located between 128.3 Mb and 282.7 Mb on chromosome 2 (Fig. 3B; Table S4). 
In the second intercross (Gabon males × Guadeloupe females), we also detected four QTL 10 
associated with infection status albeit with lower statistical support (FDR<0.05) between 37.0 
Mb and 344.8 Mb on chromosome 2 (Fig. 3C; Table S4). In both intercrosses there was a 
complete lack of genotype-phenotype association signal on chromosomes 1 and 3 (Fig. 3B-C). 
The strongest QTL signals on chromosome 2 were distinct between the two intercrosses, which 
could reflect incomplete detection power and/or causative variants that are not fixed differences 15 
between the parental populations (23). Earlier genetic mapping studies of DENV susceptibility in 
Ae. aegypti also yielded different QTL sets in separate crosses, including QTL located at 
different positions of chromosome 2 (24, 25). Analyses of ancestry differences confirmed that in 
both intercrosses the significant QTL corresponded to an enrichment of the resistant parental 
genome in the resistant progeny (Fig. S3). Although our QTL mapping approach had a relatively 20 
low resolution due to the limited number of unique recombination events captured in only three 
generations, it provided clear evidence that the difference in ZIKV susceptibility between the 
Gabon and Guadeloupe colonies is governed by one or more genetic loci on chromosome 2. 
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Finally, we evaluated the significance of the observed difference in ZIKV susceptibility between 
Aaa and Aaf for transmission potential in a mouse model of ZIKV infection. Artificial infectious 
blood meals are a convenient proxy but they do not necessarily recapitulate the complexity of a 
blood meal taken on a live host, which potentially contains host factors and viral antigens that 5 
may influence virus acquisition by mosquitoes (26-28). In addition, infection probability is only 
one component of the virus transmission process, which also requires systemic dissemination 
and viral release in mosquito saliva (11). To address the limitations of artificial blood meals, we 
compared the cumulative amount of virus transmission between the Gabon and Guadeloupe 
colonies when mosquitoes acquired infection from a live host. Groups of mosquitoes from both 10 
colonies were allowed to simultaneously blood feed on the same ZIKV-infected mice (Fig. S1B). 
Following intra-peritoneal injection of the ZIKV_Cambodia_2010 strain, immunocompromised 
mice (Ifnar1-/-) from two genetic backgrounds (C57BL/6J and 129S2/SvPas) developed viremia 
that peaked 2-3 days post infection and was detectable in plasma for about one week (Fig. 4). 
Across the mouse viremic period, the proportion of infected (ZIKV-positive body) and infectious 15 
(ZIKV-positive saliva) mosquitoes roughly followed the kinetics of plasma viremia but was 
strikingly lower for Gabon than for Guadeloupe mosquitoes (Fig. 4). Accounting for differences 
between replicate mice, infection rate was significantly lower (multivariate logistic regression: 
p<0.0392) for the Gabon mosquitoes at all time points, with the exception of day 2 post mouse 
infection in the C57BL/6J strain (p=0.0898) and day 5 post mouse infection in the 129S2/SvPas 20 
strain (p=0.2976). Likewise, the proportion of infectious mosquitoes was significantly lower 
(p<0.0176) for the Gabon colony on days 2 and 3 post mouse infection in both mouse strains, as 
well as on days 1 and 5 post mouse infection (p<0.0305) in the C57BL/6J strain. Therefore, the 
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large difference in ZIKV susceptibility previously observed with artificial infectious blood meals 
translated into a substantially lower potential to transmit ZIKV of Aaf relative to Aaa. 
 
Together, our results indicate that ‘domestication’ of Ae. aegypti about 5,000-10,000 years ago 
(6, 8) was accompanied by an increase in its innate ability to acquire and transmit ZIKV. Today, 5 
some African populations of Ae. aegypti such as NGO in Western Senegal display 
morphological, behavioral and genetic features typical of Aaa populations outside Africa (7), as 
does their ZIKV susceptibility. This is consistent with an earlier study in Senegal reporting a 
cline in the relative abundance of Aaa and Aaf (based on morphological features) that correlated 
with variation in DENV susceptibility (29). Whether the differential ZIKV susceptibility 10 
between Aaa and Aaf extend to other flaviviruses than ZIKV remains to be ascertained. 
Experimental infections of the Ae. aegypti colonies from our worldwide panel with YFV (Fig. 
S4) and DENV (Fig. S5) showed a similar pattern as for ZIKV. These data are consistent with a 
higher genetic resistance of Aaf against flaviviruses in general, however without a broader panel 
of YFV and DENV strains we cannot rule out the existence of strain-specific interactions (30). It 15 
is unlikely that increased ZIKV susceptibility of the globally invasive Aaa subspecies was driven 
by relaxed natural selection because arboviruses apparently do not represent a meaningful 
selective force on mosquito populations (31). Moreover, ZIKV usually circulates in sylvatic 
cycles that involve other mosquito species than Ae. aegypti (32), reducing opportunities for 
natural selection to act. We speculate that increased susceptibility was a by-product of adaptation 20 
to the ‘domestic’ lifestyle due to genetic drift and/or genetic linkage between ‘domestic’ genes 
and susceptibility genes, but this remains to be tested. This hypothesis is supported by the 
overlap between the most significant ZIKV susceptibility QTL spanning from 128 to 189 Mb on 
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chromosome 2 and a previously identified genomic hotspot for human specialization between 
133 and 168 Mb on the same chromosome (7). For example, the human-preferring NGO 
population shows higher levels of genetic differentiation from animal-preferring populations and 
elevated levels of ‘domestic’ ancestry in this genomic region (up to 50% vs. the 37.4% genome-
wide average). 5 
 
Regardless of the underlying evolutionary mechanism, the marked difference in ZIKV 
susceptibility between Aaa and Aaf may help to explain one puzzling aspect of Zika 
epidemiology. Although ZIKV was first isolated in Uganda and is known to be present across 
most of Africa, it has yet to cause large-scale human outbreaks on this continent (33, 34). 10 
Arbovirus emergence is primarily driven by urbanization, globalization and the failure of 
prevention measures, and the risk is further modulated by region-specific factors such as the 
immune and genetic background of human populations (35, 36). The low seroprevalence of 
neutralizing antibodies against ZIKV typically observed in Africa (37-39) makes it unlikely that 
herd immunity is the main factor preventing ZIKV outbreaks. Our findings suggest that instead 15 
the lower transmission potential of Aaf could have hindered ZIKV emergence on the African 
continent. This explanation is consistent with the few examples of ZIKV circulation in human 
populations of Africa, and points to opportunities for experimental confirmation with additional 
mosquito samples. ZIKV was detected in Gabon in 2007 but the vector was presumably another 
mosquito species, Aedes albopictus (40). ZIKV circulated during 2016-2017 in Angola (41) but a 20 
recent study found that an Ae. aegypti population from Luanda, Angola consisted of a genetic 
mixture of Aaa and Aaf (6). Possibly, a similar situation could have facilitated the large ZIKV 
outbreak that occurred in Cape Verde during 2015-2016 (42), based on the untested assumption 
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that the local Ae. aegypti population there harbors a large proportion of ‘domestic’ ancestry 
similar to the nearby populations of Western Senegal. We conclude that the evolution of human 
specialization and subsequent spread of Ae. aegypti out of Africa may have promoted arbovirus 
emergence not solely through increased vector-host contact, but also as a result of enhanced 
vector permissiveness. 5 
 
References and Notes: 
1. M. U. G. Kraemer et al., Past and future spread of the arbovirus vectors Aedes aegypti 
and Aedes albopictus. Nat Microbiol 4, 854-863 (2019). 
2. P. F. Mattingly, Genetical aspects of the Aedes aegypti problem. I. Taxonomy and 10 
bionomics. Ann Trop Med Parasitol 51, 392-408 (1957). 
3. A. Gloria-Soria et al., Global genetic diversity of Aedes aegypti. Mol Ecol 25, 5377-5395 
(2016). 
4. J. E. Brown et al., Worldwide patterns of genetic differentiation imply multiple 
'domestications' of Aedes aegypti, a major vector of human diseases. Proc Biol Sci 278, 15 
2446-2454 (2011). 
5. C. S. McBride, Genes and Odors Underlying the Recent Evolution of Mosquito 
Preference for Humans. Curr Biol 26, R41-46 (2016). 
6. P. Kotsakiozi et al., Population structure of a vector of human diseases: Aedes aegypti in 
its ancestral range, Africa. Ecol Evol 8, 7835-7848 (2018). 20 
7. N. H. Rose et al., Climate and Urbanization Drive Mosquito Preference for Humans. 
Curr Biol, (2020). Online ahead of print: https://doi.org/10.1016/j.cub.2020.06.092 
Submitted Manuscript: Confidential 
 
 
15 
 
8. J. E. Crawford et al., Population genomics reveals that an anthropophilic population of 
Aedes aegypti mosquitoes in West Africa recently gave rise to American and Asian 
populations of this major disease vector. BMC Biol 15, 16 (2017). 
9. O. J. Brady, S. I. Hay, The Global Expansion of Dengue: How Aedes aegypti Mosquitoes 
Enabled the First Pandemic Arbovirus. Annu Rev Entomol, 191-208 (2020). 5 
10. S. C. Weaver, C. Charlier, N. Vasilakis, M. Lecuit, Zika, Chikungunya, and Other 
Emerging Vector-Borne Viral Diseases. Annu Rev Med 69, 395-408 (2018). 
11. W. C. Black et al., Flavivirus susceptibility in Aedes aegypti. Arch Med Res 33, 379-388 
(2002). 
12. T. H. Aitken, W. G. Downs, R. E. Shope, Aedes aegypti strain fitness for yellow fever 10 
virus transmission. Am J Trop Med Hyg 26, 985-989 (1977). 
13. W. J. Tabachnick et al., Oral infection of Aedes aegypti with yellow fever virus: 
geographic variation and genetic considerations. Am J Trop Med Hyg 34, 1219-1224 
(1985). 
14. D. J. Gubler, S. Nalim, R. Tan, H. Saipan, J. Sulianti Saroso, Variation in susceptibility to 15 
oral infection with dengue viruses among geographic strains of Aedes aegypti. Am J Trop 
Med Hyg 28, 1045-1052 (1979). 
15. G. W. Dick, S. F. Kitchen, A. J. Haddow, Zika virus. I. Isolations and serological 
specificity. Trans R Soc Trop Med Hyg 46, 509-520 (1952). 
16. M. R. Duffy et al., Zika virus outbreak on Yap Island, Federated States of Micronesia. N 20 
Engl J Med 360, 2536-2543 (2009). 
17. D. Musso, E. J. Nilles, V. M. Cao-Lormeau, Rapid spread of emerging Zika virus in the 
Pacific area. Clin Microbiol Infect 20, O595-596 (2014). 
Submitted Manuscript: Confidential 
 
 
16 
 
18. D. Musso, A. I. Ko, D. Baud, Zika Virus Infection - After the Pandemic. N Engl J Med 
381, 1444-1457 (2019). 
19. A. T. Ciota et al., Effects of Zika Virus Strain and Aedes Mosquito Species on Vector 
Competence. Emerg Infect Dis 23, 1110-1117 (2017). 
20. C. M. Roundy et al., Variation in Aedes aegypti Mosquito Competence for Zika Virus 5 
Transmission. Emerg Infect Dis 23, 625-632 (2017). 
21. P. M. Armstrong et al., Successive blood meals enhance virus dissemination within 
mosquitoes and increase transmission potential. Nat Microbiol 5, 239-247 (2020). 
22. E. Calvez et al., Differential transmission of Asian and African Zika virus lineages by 
Aedes aegypti from New Caledonia. Emerg Microbes Infect 7, 159 (2018). 10 
23. H. Bastide, J. D. Lange, J. B. Lack, A. Yassin, J. E. Pool, A Variable Genetic 
Architecture of Melanic Evolution in Drosophila melanogaster. Genetics 204, 1307-1319 
(2016). 
24. C. F. Bosio, R. E. Fulton, M. L. Salasek, B. J. Beaty, W. C. Black, Quantitative trait loci 
that control vector competence for dengue-2 virus in the mosquito Aedes aegypti. 15 
Genetics 156, 687-698 (2000). 
25. C. Gomez-Machorro, K. E. Bennett, M. del Lourdes Munoz, W. C. Black, Quantitative 
trait loci affecting dengue midgut infection barriers in an advanced intercross line of 
Aedes aegypti. Insect Mol Biol 13, 637-648 (2004). 
26. Y. Liu et al., Evolutionary enhancement of Zika virus infectivity in Aedes aegypti 20 
mosquitoes. Nature 545, 482-486 (2017). 
Submitted Manuscript: Confidential 
 
 
17 
 
27. N. Nguyen et al., Host and viral features of human dengue cases shape the population of 
infected and infectious Aedes aegypti mosquitoes. Proc Natl Acad Sci U S A 110, 9072-
9077 (2013). 
28. Y. Zhu et al., Host serum iron modulates dengue virus acquisition by mosquitoes. Nat 
Microbiol 4, 2405-2415 (2019). 5 
29. M. Sylla, C. Bosio, L. Urdaneta-Marquez, M. Ndiaye, W. C. Black, Gene flow, 
subspecies composition, and dengue virus-2 susceptibility among Aedes aegypti 
collections in Senegal. PLoS Negl Trop Dis 3, e408 (2009). 
30. L. B. Dickson, I. Sanchez-Vargas, M. Sylla, K. Fleming, W. C. Black, Vector 
competence in West African Aedes aegypti Is Flavivirus species and genotype dependent. 10 
PLoS Negl Trop Dis 8, e3153 (2014). 
31. L. Lambrechts, M. C. Saleh, Manipulating Mosquito Tolerance for Arbovirus Control. 
Cell Host Microbe 26, 309-313 (2019). 
32. G. Gutierrez-Bugallo et al., Vector-borne transmission and evolution of Zika virus. Nat 
Ecol Evol 3, 561-569 (2019). 15 
33. A. G. Buchwald, M. H. Hayden, S. K. Dadzie, S. H. Paull, E. J. Carlton, Aedes-borne 
disease outbreaks in West Africa: A call for enhanced surveillance. Acta Trop, 105468 
(2020). 
34. D. Weetman et al., Aedes Mosquitoes and Aedes-Borne Arboviruses in Africa: Current 
and Future Threats. Int J Environ Res Public Health 15, 220 (2018). 20 
35. H. Ketkar, D. Herman, P. Wang, Genetic Determinants of the Re-Emergence of 
Arboviral Diseases. Viruses 11, 150 (2019). 
Submitted Manuscript: Confidential 
 
 
18 
 
36. A. Wilder-Smith et al., Epidemic arboviral diseases: priorities for research and public 
health. Lancet Infect Dis 17, e101-e106 (2017). 
37. J. T. Kayiwa et al., Confirmation of Zika virus infection through hospital-based sentinel 
surveillance of acute febrile illness in Uganda, 2014-2017. J Gen Virol 99, 1248-1252 
(2018). 5 
38. A. C. Willcox et al., Seroepidemiology of Dengue, Zika, and Yellow Fever Viruses 
among Children in the Democratic Republic of the Congo. Am J Trop Med Hyg 99, 756-
763 (2018). 
39. B. Kisuya, M. M. Masika, E. Bahizire, J. O. Oyugi, Seroprevalence of Zika virus in 
selected regions in Kenya. Trans R Soc Trop Med Hyg 113, 735-739 (2019). 10 
40. G. Grard et al., Zika virus in Gabon (Central Africa)--2007: a new threat from Aedes 
albopictus? PLoS Negl Trop Dis 8, e2681 (2014). 
41. S. C. Hill et al., Emergence of the Asian lineage of Zika virus in Angola: an outbreak 
investigation. Lancet Infect Dis 19, 1138-1147 (2019). 
42. O. Faye et al., Genomic Epidemiology of 2015-2016 Zika Virus Outbreak in Cape Verde. 15 
Emerg Infect Dis 26, 1084-1090 (2020). 
43. M. U. Kraemer et al., The global distribution of the arbovirus vectors Aedes aegypti and 
Ae. albopictus. eLife 4, e08347 (2015). 
44. B. N. Mansfeld, R. Grumet, QTLseqr: An R Package for Bulk Segregant Analysis with 
Next-Generation Sequencing. Plant Genome 11, 1-5 (2018). 20 
45. L. B. Dickson et al., Diverse laboratory colonies of Aedes aegypti harbor the same adult 
midgut bacterial microbiome. Parasites Vectors 11, 207 (2018). 
Submitted Manuscript: Confidential 
 
 
19 
 
46. A. Baidaliuk et al., Cell-Fusing Agent Virus Reduces Arbovirus Dissemination in Aedes 
aegypti Mosquitoes In Vivo. J Virol 93, e00705-19 (2019). 
47. A. Fontaine, D. Jiolle, I. Moltini-Conclois, S. Lequime, L. Lambrechts, Excretion of 
dengue virus RNA by Aedes aegypti allows non-destructive monitoring of viral 
dissemination in individual mosquitoes. Sci Rep 6, 24885 (2016). 5 
48. T. Fansiri et al., Genetic Mapping of Specific Interactions between Aedes aegypti 
Mosquitoes and Dengue Viruses. PLoS Genet 9, e1003621 (2013). 
49. M. Caron et al., First evidence of simultaneous circulation of three different dengue virus 
serotypes in Africa. PLoS ONE 8, e78030 (2013). 
50. E. Chungue et al., Molecular epidemiology of dengue-1 and dengue-4 viruses. J Gen 10 
Virol 76, 1877-1884 (1995). 
51. F. Rodhain, C. Hannoun, F. X. Jousset, P. Ravisse, [Isolation of the yellow fever virus in 
Paris from 2 imported human cases]. Bull Soc Pathol Exot Filiales 72, 411-415 (1979). 
52. T. H. G. Aitken, An in vitro feeding technique for artificially demonstrating virus 
transmission by mosquitoes. Mosq News 37, 130-133 (1977). 15 
53. G. Rasic, I. Filipovic, A. R. Weeks, A. A. Hoffmann, Genome-wide SNPs lead to strong 
signals of geographic structure and relatedness patterns in the major arbovirus vector, 
Aedes aegypti. BMC Genomics 15, 275 (2014). 
54. B. K. Peterson, J. N. Weber, E. H. Kay, H. S. Fisher, H. E. Hoekstra, Double digest 
RADseq: an inexpensive method for de novo SNP discovery and genotyping in model 20 
and non-model species. PLoS ONE 7, e37135 (2012). 
55. B. J. Matthews et al., Improved reference genome of Aedes aegypti informs arbovirus 
vector control. Nature 563, 501-507 (2018). 
Submitted Manuscript: Confidential 
 
 
20 
 
56. B. Langmead, C. Trapnell, M. Pop, S. L. Salzberg, Ultrafast and memory-efficient 
alignment of short DNA sequences to the human genome. Genome Biol 10, R25 (2009). 
57. H. Li et al., The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 
2078-2079 (2009). 
58. T. S. Korneliussen, A. Albrechtsen, R. Nielsen, ANGSD: Analysis of Next Generation 5 
Sequencing Data. BMC Bioinformatics 15, 356 (2014). 
59. P. M. Magwene, J. H. Willis, J. K. Kelly, The statistics of bulk segregant analysis using 
next generation sequencing. PLoS Comput Biol 7, e1002255 (2011). 
60. N. Patterson et al., Ancient admixture in human history. Genetics 192, 1065-1093 (2012). 
61. H. Wickham, ggplot2: Elegant Graphics for Data Analysis (Springer-Verlag, New York, 10 
2016). 
62. J. Fox, S. Weisberg, An R Companion to Applied Regression (Sage, Thousand Oaks, CA, 
ed. Third, 2019). 
 
Acknowledgments: We thank Catherine Lallemand for assistance with mosquito rearing and the 15 
Institut Pasteur animal facility staff for the breeding of Ifnar1-/- mice. We thank the volunteers 
and the ICAReB staff for the human blood supply. We are grateful to Anna-Bella Failloux for 
sharing the YFV strain. Funding: This work was primarily funded by the European Union’s 
Horizon 2020 research and innovation programme under ZikaPLAN grant agreement no. 734584 
(to LL). This work was also supported by Agence Nationale de la Recherche (grants ANR-16-20 
CE35-0004-01, ANR-17-ERC2-0016-01 and ANR-18-CE35-0003-01 to LL), the French 
Government’s Investissement d’Avenir program Laboratoire d’Excellence Integrative Biology of 
Emerging Infectious Diseases (grant ANR-10-LABX-62-IBEID to LL and XM), the Inception 
Submitted Manuscript: Confidential 
 
 
21 
 
program (Investissement d’Avenir grant ANR-16-CONV-0005 to LL), the City of Paris 
Emergence(s) program in Biomedical Research (to LL), the QIMR Berghofer Medical Research 
Institute (Seed Funding Grant to GR), the Programme Opérationnel FEDER-Guadeloupe-Conseil 
Régional 2014-2020 (grant 2015-FED-192 to AVR), the European Union's Horizon 2020 
Research and innovation programme under “ZIKALLIANCE” grant agreement no. 734548 (to 5 
AV-R), the US National Institutes of Health (grant NIDCD R00-DC012069 to CSM), a Helen 
Hay Whitney Postdoctoral Fellowship (to NHR), the UK Medical Research Council (grant 
MC_UU_12014/8 to AK) and the CDC (J-PM). CSM is a New York Stem Cell Foundation – 
Robertson Investigator. The funders had no role in study design, data collection and 
interpretation, or the decision to submit the work for publication. Author contributions: FA and 10 
LL designed and coordinated the study. FA, SD, CM, EFM, DM, AB, SHM, LBD, ABC and 
VOA performed the mosquito experiments. IF and GR generated and analyzed the RAD-seq data 
and performed the QTL mapping. NHR performed the admixture analyses. NHR, CMR-V, AV-
R, ID, DJ, CP, MNM, JJL, AK, VD, AP, MS, JA, SO, JL, RS, J-PM and CSM performed field 
collections to initiate mosquito colonies. V-MC-L, RGJ, CTD, OumF, OusF and AAS obtained 15 
the virus isolates and organized their transfer. NHR and CSM coordinated the collection and the 
maintenance of the African mosquito panel. FA, CM, XM and LL designed and implemented the 
mouse-to-mosquito transmission assay. FA and LL wrote and revised the manuscript with input 
from all other authors. Competing interests: Authors declare no competing interests. Data and 
materials availability: Raw sequencing data were deposited to the SRA repository under 20 
accession number PRJNA640190. All other raw data are available from the Zenodo repository at 
https://doi.org/10.5281/zenodo.3981206. Sharing some of the materials is subject to material 
transfer agreements with Institut Louis Malardé, Institut Pasteur Dakar, Princeton University, 
Submitted Manuscript: Confidential 
 
 
22 
 
Universidad del Norte, Walter Reed Army Institute of Research, and the World Reference Center 
for Emerging Viruses and Arboviruses.  
 
Supplementary Materials: 
Materials and Methods 5 
Figures S1-S5 
Tables S1-S4 
References (45-62) 
  
Submitted Manuscript: Confidential 
 
 
23 
 
Figure Legends: 
Fig. 1. Native populations of Ae. aegypti in Africa are less susceptible to ZIKV than globally 
invasive populations outside Africa. A. Dose-response curves of eight field-derived Ae. aegypti 
colonies challenged by six low-passage ZIKV strains. The proportions of ZIKV-infected 
mosquitoes 7 days post oral challenge are shown as a function of the blood meal titers in log10-5 
transformed focus-forming units (FFU)/ml. Each box represents a different ZIKV strain as 
labeled at the top. The logistic regression lines are color-coded for the different mosquito 
populations. B. Geographical origins of the eight Ae. aegypti colonies and their estimated OID50 
values expressed in log10 FFU/ml for the six low-passage ZIKV strains tested in panel A. The pie 
charts show the six OID50 values estimated from the dose-response curves shown in panel A 10 
(clockwise from the top: ZIKV_Senegal_2015, ZIKV_Cambodia_2010, ZIKV_Thailand_2014, 
ZIKV_Philippines_2012, ZIKV_Puerto_Rico_2015, ZIKV_F_Polynesia_2013) and represented 
on a color scale (except for the undetermined OID50 values shown in grey). The grey background 
indicates the approximate distribution of Ae. aegypti (43). The light grey represents the globally 
invasive subspecies Aaa whereas the dark grey represents the African subspecies Aaf. 15 
 
Fig. 2. ZIKV susceptibility among African populations of Ae. aegypti correlates positively with 
their proportion of ‘domestic’ genetic ancestry. A. Dose-response curves of eight field-derived 
Ae. aegypti colonies challenged by two low-passage ZIKV strains. Colonies from Gabon and 
Guadeloupe are the same as in the worldwide panel shown in Fig. 1 and served as resistant and 20 
susceptible references, respectively. The other six colonies were derived from a panel of African 
populations sampled in a separate study (7) and abbreviated as follows: NGO=Ngoye, Senegal; 
KED=Kédougou, Senegal; KUM=Kumasi, Ghana; ENT=Entebbe, Uganda; KAK=Kakamega, 
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Kenya; RAB=Rabai, Kenya. The proportions of ZIKV-infected mosquitoes 7 days post oral 
challenge are shown as a function of the blood meal titers in log10-transformed focus-forming 
units (FFU)/ml. Each box represents a different ZIKV strain as labeled at the top. The logistic 
regression lines are color-coded for the different mosquito populations. B. Geographical origins 
of the seven African Ae. aegypti colonies and their estimated OID50 values expressed in log10 5 
FFU/ml for the two low-passage ZIKV strains tested in panel A. The pie charts show the OID50 
values estimated from the dose-response curves (left: ZIKV_Cambodia_2010; right: 
ZIKV_Senegal 2011) and represented on a color scale. The grey shading indicates the 
approximate distribution of Ae. aegypti (43). C. Relationship between ZIKV susceptibility of the 
colonies and the average proportion of ‘domestic’ genetic ancestry of their wild-caught founders, 10 
inferred by ADMIXTURE analyses (7). Note that ZIKV susceptibility is represented by OID50 
estimates for ZIKV_Cambodia_2010 and by OID75 estimates for ZIKV_Senegal_2011 because 
of the higher overall infectiousness of the latter strain. Each box represents a different ZIKV 
strain as labeled at the top. The black lines represent the square root regression results for the 
ZIKV_Cambodia_2010 strain (R2=0.761; p=0.0047) and the ZIKV_Senegal_2011 strain 15 
(R2=0.519; p=0.0437). The best-fit regression function was obtained by comparing R2 values 
between various regression models.  
 
Fig. 3. Genetic analysis of intercrossed African and non-African mosquitoes identifies genomic 
regions underlying ZIKV susceptibility. A. Dose-response curves of the parental colonies and the 20 
F1, F2, F3 and F6 generations of intercross 1 (Guadeloupe males × Gabon females) and intercross 
2 (Gabon males × Guadeloupe females) orally challenged with the ZIKV_Cambodia_2010 
strain. The percentage of ZIKV-infected mosquitoes 7 days post oral challenge is shown as a 
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function of the blood meal titers in log10-transformed focus-forming units (FFU)/ml. Each box 
represents a different intercross generation, as labeled at their top, and the lines represent the 
logistic regression results. B-C. QTL mapping results obtained for the F4 generation of intercross 
1 (B) and intercross 2 (C). The statistical significance of the genotype-phenotype association, 
averaged by 5-Mb moving windows, is shown along the three chromosomes. The horizontal red 5 
lines indicate the 0.1% (B) and 5% (C) genome-wide false discovery rate (FDR) thresholds 
calculated with the Benjamini-Hochberg method implemented in QTLseqr (44). 
 
Fig. 4. African mosquitoes have less potential than non-African mosquitoes to acquire and 
transmit ZIKV from a viremic host. Mouse-to-mosquito transmission of ZIKV was evaluated in 10 
immunocompromised (Ifnar1-/-) C57BL/6J (A) and 129S2/SvPas (B) mouse strains. The graphs 
show the time course of mouse plasma viremia (infectious titers expressed in log10-transformed 
focus-forming units [FFU]/ml, top graph), mosquito infection (percentage of ZIKV-infected 
mosquitoes 14 days post blood meal, middle graph) and mosquito infectiousness (percentage of 
mosquitoes with ZIKV-positive saliva 14 days post blood meal, bottom graph) during the mouse 15 
viremic period. In all panels, each line represents one of three replicate mice, identified by 
different symbols. In the middle and bottom graphs, each data point represents a group of 2-20 
(median 11) mosquitoes. The blue and red colors represent mosquitoes from Guadeloupe and 
Gabon, respectively. 
  20 
Submitted Manuscript: Confidential 
 
 
26 
 
 
 
 
Supplementary Materials for 
 5 
Enhanced Zika virus susceptibility of globally invasive Aedes aegypti populations 
 
Fabien Aubry, Stéphanie Dabo, Caroline Manet, Igor Filipović, Noah H. Rose, Elliott F. Miot, 
Daria Martynow, Artem Baidaliuk, Sarah H. Merkling, Laura B. Dickson, Anna B. Crist, Victor 
O. Anyango, Claudia M. Romero-Vivas, Anubis Vega-Rúa, Isabelle Dusfour, Davy Jiolle, 10 
Christophe Paupy, Martin N. Mayanja, Julius J. Lutwama, Alain Kohl, Veasna Duong, Alongkot 
Ponlawat, Massamba Sylla, Jewelna Akorli, Sampson Otoo, Joel Lutomiah, Rosemary Sang, 
John-Paul Mutebi, Van-Mai Cao-Lormeau, Richard G. Jarman, Cheikh T. Diagne, Oumar Faye, 
Ousmane Faye, Amadou A. Sall, Carolyn S. McBride, Xavier Montagutelli, Gordana Rašić, 
Louis Lambrechts 15 
 
Correspondence to: louis.lambrechts@pasteur.fr 
 
 
This PDF file includes: 20 
 
Materials and Methods 
Figs. S1 to S5 
Tables S1 to S4 
 25 
  
Submitted Manuscript: Confidential 
 
 
27 
 
Materials and Methods 
Ethics and regulatory information 
This study used human blood samples to prepare mosquito artificial infectious blood meals. 
For that purpose, healthy blood donor recruitment was organized by the local investigator 
assessment using medical history, laboratory results and clinical examinations. Biological 5 
samples were supplied through the participation of healthy adult volunteers at the ICAReB 
biobanking platform (BB-0033-00062/ICAReB platform/Institut Pasteur, Paris/BBMRI 
AO203/[BIORESOURCE]) of the Institut Pasteur in the CoSImmGen and Diagmicoll protocols, 
which had been approved by the French Ethical Committee Ile-de-France I. The Diagmicoll 
protocol was declared to the French Research Ministry under reference 343 DC 2008-68 COL 1. 10 
All adult subjects provided written informed consent. The mouse experiments were approved by 
the Institut Pasteur Animal Ethics Committee (project number dap170045) and authorized by the 
French Ministry of Research (authorization number 12861). The Institut Pasteur animal facility 
had received accreditation from the French Ministry of Agriculture to perform experiments on 
live animals in compliance with the French and European regulations on the care and protection 15 
of laboratory animals (authorization number 75-15-01). Mosquito eggs were collected and 
exported with the permission from local institutions and/or governments as required (Kenya 
SERU No. 3433; Gabon AR0020/14/MESR/CENAREST/CG/CST/CSAR; Uganda permit 2014-
12-134). 
 20 
Mosquitoes 
Fourteen recently established Ae. aegypti colonies (2-16 laboratory generations) were 
chosen based on their geographical origins to best represent both the ancestral and the invasive 
range of the species (Table S1). Mosquitoes were reared under controlled insectary conditions 
(28°C, 12h:12h light:dark cycle and 70% relative humidity). Prior to performing the 25 
experiments, their eggs were hatched synchronously in a vacuum chamber for 1 hour. Their 
larvae were reared in plastic trays containing 1.5 liter of dechlorinated tap water and 
supplemented with a standard diet of Tetramin (Tetra) fish food at a density of 200 larvae per 
tray. After emergence, adults were kept in 30 × 30 × 30 cm BugDorm-1 insect cages (BugDorm) 
with permanent access to 10% sucrose solution. The gut bacterial microbiome of diverse Ae. 30 
aegypti colonies (including four colonies included in the present study) reared in the same 
insectary was remarkably similar and is therefore unlikely to be confounded with genetic effects 
(45). However, the colonies were not systematically screened for insect-specific flaviviruses, 
which can influence arbovirus infection (46). For each experiment, all the mosquito colonies 
were reared simultaneously in the same insectary. 35 
 
Virus strains 
Seven wild-type ZIKV strains (with <5 passages in cell culture) were chosen based on their 
geographical origin and year of isolation to best represent the current breadth of ZIKV genetic 
diversity (Table S2). ZIKV strains were obtained from the World Reference Center for Emerging 40 
Viruses and Arboviruses at the University of Texas Medical Branch (PRVABC59, FSS13025), 
the Armed Forces Research Institute of Medical Sciences (PHL/2012/CPC-0740, 
THA/2014/SV0127-14), the Institut Louis Malardé in French Polynesia (PF13/251013-18) and 
the Institut Pasteur in Dakar (Kedougou2011, Kedougou2015). Viruses were amplified in the 
C6/36 Aedes albopictus cell line (ATCC CRL-1660) to generate high-titered stocks as previously 45 
described (47). Their infectious titers were measured in C6/36 cells using a standard focus-
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forming assay (FFA) as previously described (47). A commercial mouse anti-flavivirus group 
antigen monoclonal antibody (MAB10216; Merck Millipore) diluted 1:1,000 in phosphate-
buffered saline (PBS; Gibco Thermo Fisher Scientific) supplemented with 1% bovine serum 
albumin (BSA; Interchim) was used as the primary antibody. The secondary antibody was an 
Alexa Fluor 488-conjugated goat anti-mouse antibody (A-11029; Life Technologies) diluted 5 
1:500 in PBS supplemented with 1% BSA. The DENV-1 KDH0030A strain was isolated in 
Thailand in 2010 (48). The DENV-2 GA2_60 and the DENV-3 GA28-7 strains were isolated in 
Gabon in 2010 (49). The DENV-4 63632 strain was isolated in Senegal in 1983 (50). The YFV 
S79 strain was isolated in Senegal in 1979 (51). 
 10 
Mouse and cell lines 
C57BL/6J and 129S2/SvPas mice deficient for the interferon type I receptor 
(Ifnar1tm1Agt/tm1Agt, knockout allele RRID MGI_1930950), noted Ifnar1-/- mice, were maintained 
under specific pathogen-free conditions with a 14h:10h light:dark cycle and food and water ad 
libitum at the Institut Pasteur animal facility. All of the mice were euthanized by cervical 15 
dislocation when the humane endpoints were obtained or at the end of the experiments. The Ae. 
albopictus cell line C6/36 (ATCC CRL-1660) was maintained at 28°C under atmospheric CO2 in 
tissue-culture flasks with non-vented caps, in Leibovitz’s L-15 medium complemented with 10% 
fetal bovine serum (FBS), 2% tryptose phosphate broth (Gibco ThermoFisher Scientific), 1× 
non-essential amino acids (Gibco ThermoFisher Scientific), 10 U/ml of penicillin (Gibco 20 
Thermo Fisher Scientific) and 10 µg/ml of streptomycin (Gibco ThermoFisher Scientific). The 
Cercopithecus aethiops cell line Vero (ATCC CCL-81) was maintained at 37°C under 5% CO2 
in tissue-culture flasks with vented caps, in Dulbecco’s Modified Eagle Medium (DMEM, high 
glucose, GlutaMAX supplement, Gibco ThermoFisher Scientific) without sodium pyruvate and 
complemented with 10% FBS, 10 U/ml of penicillin, and 10 µg/ml of streptomycin.  25 
 
Artificial infectious blood meals 
Mosquitoes were orally challenged with ZIKV, DENV and YFV by membrane feeding as 
previously described (46). Briefly, three- to seven-day-old females deprived of sucrose solution 
for 24 hours were offered an artificial infectious blood meal for 15 min using a Hemotek 30 
membrane-feeding apparatus (Hemotek Ltd.) with porcine intestine as the membrane. Blood 
meals consisted of a 2:1 mix of washed human erythrocytes and virus suspension. To establish 
the dose responses, the mosquitoes were exposed to different virus concentrations by diluting the 
virus stocks in cell culture medium prior to preparing the artificial infectious blood meal. 
Adenosine triphosphate (Merck) was added to the blood meal as a phagostimulant at a final 35 
concentration of 10 mM. Fully engorged females were sorted on wet ice, transferred into 1-pint 
cardboard containers and maintained under controlled conditions (28°±1°C, 12h:12h light:dark 
cycle and 70% relative humidity) in a climatic chamber with permanent access to 10% sucrose 
solution. After 7 days of incubation, the mosquito bodies were homogenized individually in 300 
µl of squash buffer (Tris 10 mM, NaCl 50 mM, EDTA 1.27 mM with a final pH adjusted to 8.2) 40 
supplemented with 1 µl of proteinase K (Eurobio Scientific) for 55.5 µl of squash buffer. The 
body homogenates were clarified by centrifugation and 100 µl of each supernatant were 
incubated for 5 min at 56ºC followed by 10 min at 98ºC to extract viral RNA. Detection of ZIKV 
RNA was performed using a two-step RT-PCR reaction to generate a 191-bp amplicon located in 
a conserved region of the ZIKV genome from the 3’ end of the NS1 gene to the 5’ end of NS2A 45 
gene (forward primer [F]: 5’-GTATGGAATGGAGATAAGGCCCA-3’; reverse primer [R]: 5’-
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ACCAGCACTGCCATTGATGTGC-3’). Specific primer pairs were used to detect DENV-1 (F: 
5’-GGAAGGAGAAGGACTCCACA-3’; R: 5’-ATCCTTGTATCCCATCCGGCT-3’), DENV-2 
(F: 5’-CTGCACAAGCTAGGCTACAT-3’; R: 5’-AGTGTCATCGGCGTACATTG-3’), DENV-
3 (F: 5’- AGAAGGAGAAGGACTGCACA-3’; R: 5’-ATTCTTGTGTCCCAACCGGCT-3’), 
DENV-4 (F: 5’-GAAGGTCTGCATAGGTTGGGAT-3’; R: 5’- 5 
TGATTCTTGTGTCCCAGCCTG-3’), and YFV (F: 5’- GCGTAAGGCTGGAAAGAGTG-3’; 
R: 5’-CTTCCTCCCTTCATCCACAA-3’). The total RNA was reverse transcribed into cDNA 
using random hexameric primers and the M-MLV reverse transcriptase (ThermoFisher 
Scientific) by the following program: 10 min at 25°C, 50 min at 37°C and 15 min at 70°C. The 
cDNA was subsequently amplified using DreamTaq DNA polymerase (ThermoFisher 10 
Scientific). For this step, 20-µl reaction volumes contained 1× of reaction mix and 10 µM of 
primers. The thermocycling program was 2 min at 95°C, 35 cycles of 30 sec at 95°C, 30 sec at 
60°C, and 30 sec at 72°C with a final extension step of 7 min at 72°C. Amplicons were 
visualized by electrophoresis on a 2% agarose gel.  
Mouse-to-mosquito ZIKV transmission assay 15 
Ten-week-old Ifnar1-/- mice were intra-peritoneally injected with a 200-µl inoculum 
containing 105 focus-forming units (FFU) of the ZIKV_Cambodia_2010 strain. From day 1 to 
day 7 post inoculation, mice were anesthetized daily using 80 mg/kg of ketamine and 5 mg/kg of 
xylazine administered by the intra-peritoneal route. During mouse anesthesia, 10 µl of blood 
were collected by tail incision to subsequently measure viremia. The blood sample were then 20 
diluted in 45 µl of PBS and centrifuged at 4°C for 5 min at 6,000×g for plasma separation. 
Plasma viremia was determined by FFA in Vero cells as previously described (46). Each 
anesthetized mouse was placed on the netting-covered top of two 1-pint cardboard boxes 
containing two- to four-day-old female mosquito previously deprived of sucrose solution for 24 
hours. One box contained 25 female mosquitoes from Gabon while the other one contained 25 25 
female mosquitoes from Guadeloupe. All 50 female mosquitoes were allowed to simultaneously 
blood feed on the same mouse for 15 min. Fully engorged females were sorted on wet ice, 
transferred into fresh 1-pint cardboard containers and maintained under controlled conditions 
(28°±1°C, 12h:12h light:dark light cycle and 70% relative humidity) in a climatic chamber with 
permanent access to 10% sucrose solution. After 14 days of incubation, the mosquitoes were 30 
paralyzed with triethylamine to perform in vitro salivation as described previously (52). The 
proboscis of each female was inserted into a 20-µl pipet tip containing 10 µl of FBS. After 30 
min of salivation, the saliva-containing FBS was mixed with 30 µl of Leibovitz’s L-15 medium 
and stored at -80°C for later testing. The saliva samples were subsequently thawed and 
inoculated onto C6/36 cells for ZIKV titer determinations by FFA as described above without 35 
subsequent dilution. Their bodies were homogenized and tested for ZIKV infections by RT-PCR 
as described above. 
Mosquito intercrosses  
In order to perform QTL mapping by bulk segregant analysis (23), two reciprocal crosses 
were set up between a ZIKV-resistant parental colony (Gabon) and a ZIKV-susceptible colony 40 
(Guadeloupe). The initial crosses were followed by several non-overlapping generations of 
interbreeding, and phenotypic selection was conducted only in the final generation. Intercross 1 
was initiated by mixing 132 virgin females from the 10th laboratory generation of the Gabon 
colony with 150 virgin males from the 7th laboratory generation of the Guadeloupe colony. 
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Intercross 2 was initiated by mixing 150 virgin males from the 10th laboratory generation of the 
Gabon colony with 128 virgin females from the 7th laboratory generation of the Guadeloupe 
colony. To sex-sort the virgin individuals, the larvae from each colony were reared as described 
above and their pupae were individually isolated in plastic tubes prior to adult emergence. Adults 
were maintained in a 30×30×30 cm Bugdorm-1 insect cage as described above. During 5 
subsequent generations, the intercross progeny was maintained by mating and oviposition en 
masse of 800-1,000 adults at each generation. Intercross females of generations F1, F2, F3, F4 and 
F6 were orally exposed to artificial ZIKV infectious blood meals and their ZIKV susceptibility 
was determined on day 7 post blood meal as described above. The head, thorax and legs of each 
female were used to extract genomic DNA using the NucleoSpin 96 Tissue kit (Macherey-10 
Nagel) according to the manufacturer’s instructions. The amount of DNA isolated from each 
individual was quantified using the Picogreen (Thermo Fisher Scientific) reagent following the 
manufacturer’s instructions. 
 
Restriction-site associated DNA sequencing 15 
Twelve sequencing pools (2 reciprocal crosses × 2 phenotypes [resistant, susceptible] + 2 
parental colonies, in duplicate), each consisting of 48 individuals, were prepared to perform 
restriction site-associated DNA sequencing (RAD-seq) according to established methods (53). 
Individual DNA concentrations were adjusted prior to pooling so that each individual contributed 
the same amount of DNA to the pool. A modified version of the original double-digest RAD-seq 20 
protocol (54) was used, as previously described (53). Briefly, 200 ng of DNA per pool was 
digested with NlaIII and MluCI restriction enzymes (New England Biolabs). The resulting 
digestions were cleaned with SPRI magnetic beads and barcoded using modified Illumina P1 and 
P2 adapters that enable unique identification of each pool. The barcoded fragments from all 
pools were combined, cleaned with SPRI magnetic beads and size-selected using the Blue Pippin 25 
2% agarose kit (Sage Sciences) to retain fragments of 300-450 bp in length. The library was 
finalized after 10 PCR cycles using Phusion High-Fidelity PCR Master Mix (New England 
Biolabs) and Illumina primers, and sequenced on a NextSeq 500 instrument (Illumina) using the 
paired-end (2×150 bp) chemistry. Raw sequencing data were deposited to the NCBI SRA 
repository under accession number PRJNA640190. Sequencing data were processed (trimmed to 30 
90 bp and filtered for phred>20) using a previously developed bash script (53), and the high-
quality reads were aligned to the AaegL5 reference genome assembly (55) using Bowtie (56). 
Unambiguously mapped reads were processed in SAMtools (57) to generate sorted bam files, 
and single-nucleotide polymorphisms (SNPs) were called in ANGSD (58) using the likelihood-
ratio test (-snp_pval 1e-6) based on the GATK model for genotype likelihood estimation (-GL 2) 35 
for SNPs with read depth ≥46× (~0.5× per individual in a pool) and ≤1,600× to exclude outliers 
with extreme read depth. 
 
QTL mapping 
QTL mapping was performed with the R package QTLseqr v0.7.5.2 (44), which relies on a 40 
G’ statistic adapted for bulk segregant analysis with high-throughput sequencing data (59). The 
G’ statistic is calculated for each SNP based on the observed and expected allele depths and 
adjusted with a tricube smoothing kernel. The smoothing allows for noise reduction and accounts 
for linkage disequilibrium between SNPs. G’ was close to being log-normally distributed in both 
intercrosses, allowing p values to be estimated for each SNP using non-parametric estimation of 45 
the null distribution of G’ (59). To summarize the ancestry difference between the phenotypic 
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pools (resistant vs. susceptible), for each biallelic SNP an ancestry difference value was 
calculated as ad=(fR – fS)/(pR – pS) where pR is the frequency of the major allele in the resistant 
parent (Gabon), pS is the frequency of this allele in the susceptible parent (Guadeloupe), fR is the 
frequency of this allele in the resistant progeny and fS is the frequency of this allele in the 
susceptible progeny (23). The ad value represents the proportion of ancestry from the resistant 5 
parent in the resistant progeny and was averaged by 5-Mb moving window. The analysis of ad 
was restricted to SNPs with large differences in allele frequency between the parents (pR – pS 
≥0.25). 
 
Genetic ancestry analyses 10 
The relationship between ZIKV susceptibility and ‘domestic’ genetic ancestry was 
analyzed using previously published information for NGO, KED, KUM, ENT, KAK and RAB 
colonies (7) and the newly generated RAD-seq data for Gabon and Guadeloupe colonies. A total 
of 72,721 SNPs were identified in the RAD-seq data from the Guadeloupe and Gabon colonies 
that had >20 reads in both colonies, were polymorphic in at least one of them, and overlapped 15 
with maximum-likelihood allele frequency estimates for wild-caught founders of the other 
African colonies (7). Signals of admixture were tested by ABBA-BABA or D statistics (60) 
using a block jackknife of sets of 100 consecutive SNPs to calculate Z scores and p values using 
known non-admixed populations (BKK, SAN, ENT, and LPV, see ref. (7)) as references. The 
null hypothesis of simple tree-like relationships was rejected for both colonies (Gabon: Z 20 
score=2.19; Guadeloupe: Z score=-3.13). Admixture proportions were estimated by the f4 ratio, 
as follows: for Gabon, f4(SAN, KED; Gabon, LPV)/f4(SAN, KED; BKK, LPV); for Guadeloupe 
f4(LPV, BKK; SAN, Guadeloupe)/f4(LPV, BKK; KED, Guadeloupe) (7, 60). In the case of 
Guadeloupe, deviations from simple tree-like relationships were most consistent with potential 
past gene flow between South America and Africa, rather than admixture in Guadeloupe, so this 25 
population was designated as having fully ‘domestic’ ancestry.  
 
Statistics  
Statistical analyses of phenotypic data were performed using the R software version 3.5.2 
(www.r-project.org) and JMP version 10.0.2 (www.jmpdiscovery.com). Graphical 30 
representations were generated with the R package ggplot2 (61). The proportion of infected 
mosquitoes and the proportion of infectious mosquitoes were analyzed by logistic regression of 
the corresponding binary phenotype (ZIKV-positive=1, ZIKV-negative=0), followed by an 
analysis of deviance with the R package car (62) or likelihood-ratio χ2 tests in JMP. For dose-
response analyses of infection rates, the logistic model included the infectious dose (log10-35 
transformed blood meal titer) as a covariate and the OID50 and OID75 values and their respective 
95% confidence intervals were derived from the logistic fits. The effect of the mosquito 
population on infection and transmission rates in mouse experiments were analyzed for each 
time point and each mouse strain separately using replicate mouse as a covariate. The replicate 
mouse × population interaction was removed from the model because it was always statistically 40 
non-significant (p>0.05). The potential influence of the number of laboratory generations on 
ZIKV susceptibility was assessed by analysis of variance of OID50 estimates including the virus 
strain as a covariate. 
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Fig. S1. 
Experimental infections of mosquitoes. A. Flowchart of the membrane-feeding assay to measure 
ZIKV, DENV and YFV susceptibility. B. Flowchart of the mouse-to-mosquito ZIKV 5 
transmission assay. 
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Fig. S2. 
Genetic mapping strategy. Flowchart of the QTL mapping strategy based on the intercross 
between a ZIKV-resistant parent from Gabon and a ZIKV-susceptible parent from Guadeloupe, 
followed by bulk segregant analysis. The white circle represents a hypothetical susceptibility 5 
locus and the grey circle represents a hypothetical resistance locus. 
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Fig. S3. 
Ancestry difference between phenotypic pools in the intercross progeny. The ancestry difference 
(ad) value represents the proportion of ancestry from the resistant parent in the resistant progeny 
and is shown in the two reciprocal intercrosses as the average by 5-Mb moving window for SNPs 5 
whose difference in allele frequency was ≥25% between the resistant (Gabon) and susceptible 
(Guadeloupe) parents. 
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Fig. S4. 
Dose-response curves of eight field-derived Ae. aegypti colonies orally challenged by YFV. The 
proportions of YFV-infected mosquitoes 7 days post infectious blood meal are shown as a 
function of the blood meal titers in log10-transformed focus-forming units (FFU)/ml. The lines 5 
represent the logistic regression results.   
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Fig. S5. 
Dose-response curves of Ae. aegypti colonies from Gabon and Guadeloupe orally challenged by 
the four DENV types. The proportions of DENV-infected mosquitoes 7 days post infectious 
blood meal are shown as a function of the blood meal titers in log10-transformed focus-forming 5 
units (FFU)/ml. The lines represent the logistic regression results.  
 
 
  
Submitted Manuscript: Confidential 
 
 
37 
 
Table S1. 
Aedes aegypti colonies included in this study. The names of the mosquito colonies used in the 
study, their country of origin, locality, year of collection and number of generations spent in the 
laboratory prior to this study are shown. The percentage of ‘domestic’ genetic ancestry (% Aaa) 
was inferred from the whole-genome sequences of the wild-caught progenitors or from RAD-seq 5 
data generated from colonized individuals (*). Und=undetermined. 
 
Name in this study Country Locality Year Generation % Aaa 
Thailand Thailand Kamphaeng Phet 2013 13-14 Und 
Cambodia Cambodia Phnom Penh 2015 8-9 Und 
Colombia Colombia Barranquilla 2017 2-3 Und 
F_Guiana French Guiana Cayenne 2015 5-6 Und 
Guadeloupe Guadeloupe Saint François 2015 6-13 100* 
Gabon Gabon Lopé 2014 9-16 7.30* 
Uganda Uganda Zika 2016 4-5 Und 
Cameroon Cameroon Bénoué 2014 7-8 Und 
NGO Senegal Ngoye 2018 5 37.4 
KED Senegal Kédougou 2018 4 0.86 
KUM Ghana Kumasi 2018 4 6.75 
KAK Kenya Kakamega 2017 6 1.66 
RAB Kenya Rabai 2017 6 7.36 
ENT Uganda Entebbe 2015 12 0.00 
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Table S2. 
ZIKV strains included in this study. The name of the ZIKV strains with their country of origin, 
original strain name, source of isolation, year of collection and the passage history prior to use in 
this study are indicated. TS: Toxorhynchites splendens mosquitoes; C6/36: Aedes albopictus 
cells; Vero: green monkey kidney cells; SM: suckling mouse brains. 5 
 
Name in this study Country Strain ID Source Year Passage history 
ZIKV_F_Polynesia_2013 French Polynesia PF13/251013-18 Human serum 2013 C6/36-4 
ZIKV_Puerto_Rico_2015 Puerto 
Rico 
PRVABC59 Human serum 2015 Vero-2; C6/36-3 
ZIKV_Philippines_2012 Philippines CPC-0740 Human serum 2012 TS-1; C6/36-2; Vero-1; C6/36-1 
ZIKV_Thailand_2014 Thailand SV0127-14 Human serum 2014 TS-1; C6/36-2; 
Vero-1; C6/36-1 
ZIKV_Cambodia_2010 Cambodia FSS13025 Human serum 2010 Vero 2; SM-1; C6/36-1 
ZIKV_Senegal_2011 Senegal Kedougou2011 Pool of Aedes spp. 
and Mansonia spp. 2011 C6/36-2 
ZIKV_Senegal_2015 Senegal Kedougou2015 
Pool of Aedes spp. 
and Mansonia spp. 2015 C6/36-2 
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Table S3. 
ZIKV susceptibility of Aedes aegypti colonies included in this study. The table shows the estimated 50% oral infectious dose (OID50) 
values and their 95% confidence intervals derived from the logistic fits of the dose-response curves and expressed in log10-transformed 
focus-forming units (FFU)/ml. Und=undetermined; NT=not tested. 
 
Mosquito 
colony 
ZIKV_Cambodi
a_2010 
ZIKV_Philippine
s_2012 
ZIKV_F_Polynes
ia_2013 
ZIKV_Thailand_
2014 
ZIKV_Puerto_Ri
co_2015 
ZIKV_Senegal_2
015 
ZIKV_Senegal_2
011 
Cambodia 6.12 (5.53 – 6.80) 6.18 (5.77 – 6.52) 6.50 (6.25 – 6.76) 5.20 (4.81 – 5.54) 6.05 (5.54 – 6.33) 5.38 (Und – 5.85) NT 
Cameroon 7.19 (6.89 – 8.02) 7.00 (6.71 – 7.37) 6.83 (6.59 – 7.09) 6.34 (5.97 – 6.97) 6.98 (6.65 – 7.33) 6.55 (6.03 – 7.97) NT 
Colombia 5.50 (4.36 – 6.05) 5.85 (5.56 – 6.12) 6.84 (6.59 – 7.18) 6.13 (5.81 – 6.54) 6.05 (5.32 – 6.43) Und NT 
F_Guiana 5.14 (3.52 – 5.68) 5.25 (4.08 – 5.61) 6.03 (5.68 – 6.36) 4.92 (4.63 – 5.19) 5.99 (5.36 – 6.29) 5.19 (Und – 5.84) NT 
Gabon 8.10 (7.26 – Und) 7.29 (7.08 – 7.55) 7.18 (6.91 – 8.27) 6.29 (5.87 – 7.12) 7.37 (7.04 – 7.78) 6.84 (6.48 – 7.68) 6.29 (5.96 – 6.59) 
Guadeloupe 4.83 (2.71 – 5.37) Und 5.83 (5.51 – 6.11) 4.73 (3.83 – 5.16) 5.08 (Und – 5.97) 5.69 (3.87 – 5.96) 5.56 (Und – 5.68) 
Thailand 6.04 (5.71 – 6.33) 6.13 (5.83 – 6.39) 6.30 (5.99 – 6.64) 4.98 (4.07 – 5.44) 6.19 (5.50 – 6.56) 4.88 (Und – 5.69) NT 
Uganda 7.65 (7.10 – Und) 7.16 (6.93 – 7.43) 7.82 (7.04 – Und) 6.79 (6.72 – Und) 7.75 (7.14 – 9.09) 6.59 (6.21 – 7.04) NT 
NGO 6.32 (Und – 7.04) NT NT NT NT NT 4.92 (Und – 5.61) 
KED 7.94 (7.49 – 8.74) NT NT NT NT NT 6.20 (5.73 – 6.59) 
KUM 7.45 (7.04 – 7.97) NT NT NT NT NT 5.89 (5.45 – 6.19) 
KAK 7.66 (7.26 – 8.36) NT NT NT NT NT 5.56 (3.95 – 6.03) 
RAB 6.99 (6.27 – 7.47) NT NT NT NT NT 5.85 (5.35 – 6.13) 
ENT 7.61 (7.06 – 8.40) NT NT NT NT NT 5.56 (4.48 – 5.91) 
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Table S4. 
QTL mapping results. The table shows the statistically significant QTL detected in the two reciprocal intercrosses, their genomic 
position, SNP density, and G’ summary statistics. 
 
Intercross Chr Start End Length 
No. 
SNPs 
Mean no. 
SNPs/Mb 
Max G' Position 
Max G' 
Mean 
G' 
Std. 
dev. G' 
Mean p 
value 
Mean q 
value 
1 2 128307858 189268199 60960341 12605 207 11.90362 174220367 9.98161 0.64340 2.91E-05 0.000681 
1 2 199321667 200588341 1266674 315 249 8.99794 200141717 8.96851 0.01793 9.03E-05 0.000975 
1 2 208222803 221309132 13086329 2919 223 10.55020 218672721 9.63389 0.37708 3.87E-05 0.000714 
1 2 239380068 250368015 10987947 2756 251 10.60863 244607604 9.77163 0.49641 3.57E-05 0.000709 
1 2 266331252 282747300 16416048 3243 198 9.33820 277970508 9.16086 0.08385 6.83E-05 0.000864 
2 2 37047085 37135634 88549 33 373 3.85928 37092592 3.85673 0.00163 0.002061701 0.049001 
2 2 284547688 306776528 22228840 4304 194 4.38860 300209720 4.09978 0.13919 0.000623971 0.023462 
2 2 309872477 332550739 22678262 4102 181 4.64790 326149498 4.21929 0.19776 0.000447625 0.020022 
2 2 337389780 344844034 7454254 1403 188 4.11790 340953347 3.98689 0.07804 0.001035143 0.031122 
 
 




